Preparation of a MVL-Ca-Alg/CS MEMs system with add-on effect for type 2 diabetes treatment

References

• Cho, N. H. Q&A: Five questions on the 2015 IDF Diabetes Atlas. Diabetes Res. Clin. Pract. 2016, 115, 157–159.
   PubMed Web of Science ®Google Scholar
• Laimer, M.; Jenni, S.; Stettler, C. Insulin therapy in type 2 diabetes: A review of “when” over “how” up to “why”. Praxis 2015, 104, 181–185.
   PubMedGoogle Scholar
• Turner, N. C.; Clapham, J. C. Insulin Resistance, Impaired Glucose Tolerance and Non-insulin-dependent Diabetes, Pathologic Mechanisms and Treatment: Current Status and Therapeutic Possibilities; Birkhäuser: Basel, 1998; pp. 33–94.
   Google Scholar
• Setter, S. M.; Iltz, J. L.; Thams, J.; Campbell, R. K. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy. Clin. Ther. 2003, 25, 2991–3026.
   PubMed Web of Science ®Google Scholar
• Campbell, I.; Howlett, H. Worldwide experience of metformin as an effective glucose‐lowering agent: A meta‐analysis. Diabetes/Metab. Res. Rev. 1995, 11, S57–S62.
   PubMed Web of Science ®Google Scholar
• Garber, A.; Klein, E.; Bruce, S.; Sankoh, S.; Mohideen, P. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes Obes. Metab. 2006, 8, 156–163.
   PubMed Web of Science ®Google Scholar
• Chan, J. Y. C.; Leyk, M.; Frier, B. M.; Tan, M. H. Relationship between HbA(1c) and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin. Diabetes Metab. Res. Rev. 2009, 25, 224–231.
   PubMed Web of Science ®Google Scholar
• Liou, Y. S.; Ma, T.; Tien, L. Y.; Lin, C. M.; Jong, G. P. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: A retrospective longitudinal cohort study. Hypertens. Res. 2009, 32, 496–499.
   PubMed Web of Science ®Google Scholar
• Chrysant, S. G.; Izzo, J. L.; Kereiakes, D. J.; Littlejohn, T.; Oparil, S.; Melino, M.; Lee, J.; Fernandez, V.; Heyrman, R. Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: A subpopulation analysis of the TRINITY study. J. Am. Soc. Hypertens. 2012, 6, 132–141.
   PubMed Web of Science ®Google Scholar
• Tan, X. Y.; Hu, J. B. Combination therapy for type 2 diabetes: Dapagliflozin plus metformin. Expert Opin. Pharmacother. 2016, 17, 117–126.
   PubMed Web of Science ®Google Scholar
• Joglekar, M. M.; Bavkar, L. N.; Sistla, S.; Arvindekar, A. U. Effective inhibition of protein glycation by combinatorial usage of limonene and aminoguanidine through differential and synergistic mechanisms. Int. J. Biol. Macromol. 2017, 99, 563–569.
   PubMed Web of Science ®Google Scholar
• Davidson, E. P.; Coppey, L. J.; Shevalye, H.; Obrosov, A.; Kardon, R. H.; Yorek, M. A. Impaired corneal sensation and nerve loss in a type 2 rat model of chronic diabetes is reversible with combination therapy of menhaden oil, alpha-lipoic acid, and enalapril. Cornea 2017, 36, 725–731.
   PubMed Web of Science ®Google Scholar
• Zhong, D.; Liu, Z.; Xie, S.; Zhang, W.; Zhang, Y.; Xue, W. Study on poly(D,L-lactic) microspheres embedded in calcium alginate hydrogel beads as dual drug delivery systems. J. Appl. Polym. Sci. 2013, 129, 767–772.
   Web of Science ®Google Scholar
• van Leusden, P.; den Hartog, G. J. M.; Bast, A.; Postema, M.; van der Linden, E.; Sagis, L. M. C. Strength of microbeads for the encapsulation of heat sensitive, hydrophobic components. Food Hydrocolloids 2016, 56, 318–324.
   Web of Science ®Google Scholar
• Liu, Y.; He, P.; Wang, S.; Sun, X.; Chen, A. Preparation of embolic NEMs loading capecitabine. J. Mater. Sci. Mater. Med. 2013, 24, 155–160.
   PubMed Web of Science ®Google Scholar
• Park, K.; Park, J. S.; Woo, D. G.; Yang, H. N.; Chung, H. M.; Park, K. H. The use of chondrogenic differentiation drugs to induce stem cell differentiation using double bead microsphere structure. Biomaterials 2008, 29, 2490–2500.
   PubMed Web of Science ®Google Scholar
• Patil, N. H.; Devarajan, P. V. Insulin-loaded alginic acid nanoparticles for sublingual delivery. Drug Deliv. 2016, 23, 429–436.
   PubMed Web of Science ®Google Scholar
• Koshiyama, K.; Wada, S. Collapse of a lipid-coated nanobubble and subsequent liposome formation. Sci. Rep. 2016, 6, 8.
   PubMed Web of Science ®Google Scholar
• Moses, R. Repaglinide in combination therapy with metformin in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 1999, 107, S136–S139.
   PubMed Web of Science ®Google Scholar
• Tong, P. C.; Chow, C. C.; Jorgensen, L. N.; Cockram, C. S. The contribution of metformin to glycaemic control in patients with type 2 diabetes mellitus receiving combination therapy with insulin. Diabetes Res. Clin. Pract. 2002, 57, 93–98.
   PubMed Web of Science ®Google Scholar
• Delcea, M.; Madaboosi, N.; Yashchenok, A. M.; Subedi, P.; Volodkin, D. V.; De Geest, B. G.; Mohwald, H.; Skirtach, A. G. Anisotropic multicompartment micro-; and nano-capsules produced via embedding into biocompatible PLL/HA films. Chem. Commun. 2011, 47 2098–2100.
   PubMed Web of Science ®Google Scholar
• Liu, Y. G.; He, P.; Wang, S. B.; Sun, X. Z.; Chen, A. Z. Preparation of embolic NEMs loading capecitabine. J. Mater. Sci. Mater. Med. 2013, 24, 155–160.
   PubMed Web of Science ®Google Scholar